Has Eli Lilly Stock Peaked?

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first healthcare company to top a $1 trillion valuation, perhaps as early as this year.But over the past three months, the stock has fallen by 14% as the recent election results don't appear to be inspiring much enthusiasm around the business. Fears of heightened oversight in the industry could weigh on not just Eli Lilly, but healthcare stocks as a whole. Plus, there is also the concern that the stock's high valuation may finally be catching up to it.Has Eli Lilly's stock indeed peaked, and could this be the start of a much broader sell-off, or is now a potentially good time to add the healthcare giant to your portfolio?Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool